HLA genes in ANCA-associated vasculitides

Experimental and Clinical Immunogenetics

Volumn 14, Issue 3, 1998, Pages 196-205

  Griffith, Megan E ^a   Pusey, Charles D ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

ANCA; Autoimmunity; HLA genes; Systemic vasculitis; T lymphocytes

Indexed keywords

HLA ANTIGEN; NEUTROPHIL CYTOPLASMIC ANTIBODY; TRYPSIN INHIBITOR;

AUTOIMMUNE DISEASE; CHURG STRAUSS SYNDROME; FAMILIAL DISEASE; HLA TYPING; HUMAN; IMMUNOGENETICS; IN VITRO STUDY; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; SYSTEMIC VASCULITIS; T LYMPHOCYTE; WEGENER GRANULOMATOSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOIMMUNITY; HLA ANTIGENS; HUMANS; IMMUNE TOLERANCE; VASCULITIS;

EID: 6844236987     PISSN: 02549670     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Knudson BB, Joergensen T, Munch-Jensen B: Wegener's granulomatosis in a family. Scand J Rheumatol 1988;17:225-227.
2. Muniam M, Moreno J, Campora RG: Wegener's granulomatosis in two sisters. Ann Rheum Dis 1986; 45:417-421.
3. Rottem M, Cotch MF, Fauci AS, Hoffman GS: Familial vasculitis: Report of two families, J Rheumatol 1994;21:561-563.
4. Heuze-Claudot L, Leroy B, Chevailler A, Noel L, Cau D, Danel P, Beauvais P. ANCA-associated pulmonary-renal syndrome (abstract). Clin Exp Immunol 1993;93 (suppl 1):40.
5. Franssen CFM, Ter Maaten JC, Hoorntje SJ: Brother and sister with myeloperoxidase associated autoimmune disease Ann Rheum Dis 1994;53:213.
6. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travi WD, Rottem M, Fauci AS: Wegener granulomatosis: An analysis of 158 patients. Ann Intern Med 1992; 116: 488-498.
7. Esnault VLM, Testa A, Aucrain M, Roge C, Hamidou M, Barrier J, Sesboue R, Martin JP, Lesavre P: Alpha 1 anitrypsin genetic polymorphism in ANCA positive systemic vasculitis. Kidney Int 1993;43: 1329-1332.
8. Griffith ME, Lovegrove JU, Gaskin G, Whitehouse DB, Pusey CD, C-antineutrophil cytoplasmic antibody positivity in vasculitis patients is associated with the Z allele of alpha-I-antitrypsin, and P-anti-neutrophil cytoplasmic antibody positivity with the S allele . Nephrol Dial Transplant 1996;96.438-443.
9. Porges AJ, Redecha PB, Kimberly WT, Csernok E, Gros WL, Kimberly RP: Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa. J Immunol 1994;153:1271-1280.
10. Finn JE, Zhang Li, Agrawal S, Jayne DRW, Oliviera DBG, Mathieson PW: Molecular analysis of C3 allotypes in patients with systemic vasculitis. Nephrol Dial Transplant 1994;9:1564-1567.
11. Campbell RD, Trowsdale J: Map of the human major histocompatibility complex. Immunol Today 1993;7: 349-352
12. Bodmer JG, Marsh SGE, Albert ED, Bodmer WF, Dupont B, Erlich HA, Mach B, Mayr WR, Parham P, Sasazuki T, Screuder GMT, Strominger JL, Svejgaard A, Terasaki PI: Nomenclature for factors of the HLA system. Eur J Imunogenet 1994; 21:485-517.
13. Ohashi PS: T cell selection and autoimmunity: Flexibility and tuning. Curr Opin Immunol 1996;8:808-814.
14. Miller JFAP, Basten A: Mechanisms of tolerance to self, Curr Opin Immunol 1996;8:815-821.
15. Tivol EA, Schweitzer AN, Sharpe AH: Costimulation and autoimmunity. Curr Opin Immunol 1996;8: 822-830.
16. Lanzavecchia A: How can cryptic epitopes trigger autoimmunity? J Exp Med 1995;181:1945-1948.
17. Quarantino S, Feldmann M, Dayan CM, Acuto O, Londei M: Human self-reactive T cell clones expressing identical T cell receptor beta chains differ in their ability to recognise cryptic self-epitope. J Exp Med 1996;183:349-358.
18. Gaspari AA, Jenkins MK, Katz SI: Class II MHC-bearing keratinocytes induce antigen-specific unresponsiveness in hapten-specific Th1 clones. J Immunol 1988;141:2216-2220.
19. Sidhu S, Deacock S, Bal V, Batchelor JR, Lombardi G, Lechler RI, Human T cells cannot act as autonomous antigen-presenting cells, but induce tolerance in antigen-specific and alloreactive responder cells. J Exp Med 1992;176:875-880.
20. Moskophidis D, Lechner F, Pircher H, Zinkernagel RM: Virus persistence in acutely infected immuno-competent mice by exhaustion of antiviral cytotoxic effector T cells . Nature 1993;362:758-761.
21. Lombardi G, Sidhu S, Batchelor R, Lechler R: Anergic T cells as suppressor cells in vitro. Science 1994; 264:1587-1589.
22. Nicholson LB, Kuchroo VK: Manipulation of Th1/Th2 balance in autoimmune disease. Curr Opin Immunol 1996;8:837-842.
23. Paul C, Schoenwald U, Truckenbrodt H, Bettinotti MP, Brunnler G, Keller E, Nevinny-Stickel C, Yao Z, Albert ED: HLA-DP/DR interaction in early onset pauciarticular juvenile chronic arthritis. Immunogenetics 1993;37:442-448.
24. Rees AJ, Peters DK, Compston DA, Batchelor JR. Strong association between HLA-DRW2 and antibody-mediated Goodpasture's syndrome. Lancet 1978;i:966-968.
25. Burns AP, Fisher M, Li P, Pusey CD, Rees AJ: Molecular analysis of HLA class II genes in Goodpasture's disease. Q J Med 1995;83:93-100.
26. Fisher M, Pusey CD, Vaughan RW, Rees AJ: Susceptibility to anti-glomerular basement membrane disease is strongly associated with HLA-DRB1 genes. Kidney Int 1997;51:222-229.
27. Begovich AB, McClure GR, Suraj VC, Helmuth RC, Fildes N, Bugawan TL, Erlich HA, Klitz W: Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. J Immunol 1992;148: 249-258.
28. Griffith ME, Gaskin G, Pusey CD: Classification, pathogenesis and treatment of systemic vasculitis. Renal Failure 1996;18:785-802.
29. Tam FWK, Pusey CD: The role of T lymphocytes in extracapillary glomerulonephritis. J Nephrol 1995;8: 305-316.
30. Brouwer E, Cohen Tervaert JW, Horst G, Huitema MG, van der Giessen M, Limburg PC, Kallenberg CGM: Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders. Clin Exp Immunol 1991;83: 379-386.
31. Jayne DRW, Weetman AP, Lockwood CM: IgG subclass distribution of autoantibodies to neutrophil cytoplasmic antigens in systemic vasculitis. Clin Exp Immunol 1991;84: 476-481.
32. Griffith ME, Coulthart A, Pemberton S, Pusey CD: c-ANCA recognise a restricted number of linear epitopes of PR3 which involve the catalytic site (abstract). Sarcoidosis 1996;13:256.
33. van de Weil BA, Dolman KM, van de Meer-Gerritsen CH, Hack CE, von de Borne AEG, Goldschmeding R: Interference of Wegener's granulomatosis autoantibodies with neutrophil proteinase 3 activity. Clin Exp Immunol 1992;90:409-414.
34. Daouk GH, Palsson R, Amin Arnaout M: Inhibition of proteinase 3 by ANCA and its correlation with disease activity in Wegener's granulomatosis. Kidney Int 1995;47: 1528-1536.
35. Bolton WK, Innes D, Sturgill BC, Kaiser DL; T cells and macrophages in rapidly progressive glomerulonephritis: Clinicopathological correlates. Kidney Int 1987;32:869-876.
36. Muller GA, Muller CA, Markovic-Lipkovski J, Kilper RB, Risler T: Renal major histocompatability complex antigens and cellular components in rapidly progressive glomerulonephritis identified by monoclonal antibodies. Nephron 1988;49:132-139.
37. Schlesier M, Kaspar T, Gutfleisch J, Wolff Vorbeck G, Peter HH: Activated CD4+ and CD8+ T-cell subsets in Wegener's granulomatosis. Rheumatol Int 1995;14;213-219.
38. Stegeman CA, Cohen Tervaert JW, Huitema MG, Kallenberg CGM: Serum markers of T cell activation in relapses of Wegener's granulomatosis. Clin Exp Immunol 1993;91: 415-420.
39. Schmitt WH, Heeson C, Csernok E, Rautmann A, Gross WL: Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Arthritis Rheum 1992;35:1088-1096.
40. Griffith ME, Coulthart A, Pusey CD: T cell responses to myeloperoxidase and proteinase 3 in patients with systemic vasculitis. Clin Exp Immunol 1996;103:253-258.
41. Brouwer E, Stegeman CA, Huitema MG, Limburg PC, Kallenberg CGM: T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG). Clin Exp Immunol 1994;98: 448-453.
42. Ballieux BEPB, van der Burg SH, Hagen EC, van der Woude FJ, Melief CJM, Daha MR: Cell mediated autoimmunity in patients with Wegener's granulomatosis (WG). Clin Exp Immunol 1995;100:186-193.
43. Strimlan CV, Taswell HF, Kueppers F, DeRemee RA, McDonald TJ: HLA-A antigens of patients with Wegener's granulomatosis. Tissue Antigens 1978;11:129-131.
44. Katz P, Ailing DW, Haynes BF, Fauci AS: Association of Wegener's granulomatosis with HLA-B8. Clin Immunol Immunopathol 1979;14: 268-270.
45. Elkon KB, Sutherland DC, Rees AJ, Hughes GRV, Batchelor JR: HLA antigen frequencies in systemic vasculitis: Increase in HLA-DR2 in Wegener's granulomatosis. Arthritis Rheum 1983;26:102-105.
46. Muller GA, Gebhardt M, Kompf J, Baldwin WM, Ziegenhagen D, Bohle A: Association between rapidly progressive glomerulonephritis and the properdin factor BfF and different HLA-D region products. Kidney Int 1984;25:115-118.
47. Murty GE, Mains BT, Middleton D, Maxwell AP, Savage DA: HLA frequencies and Wegener's granulomatosis. Clin Otolaryngol 1991;16: 448-451.
48. Papiha SS, Murty GE, Ad'Hia A, Mains BT, Venning M: Association of Wegener's granulomatosis with HLA antigens and other genetic markers. Ann Rheum Dis 1992;51: 246-248.
49. Spencer SJW, Burns A, Gaskin G, Pusey CD, Rees AJ: HLA class II specificities in vasculitis with antibodies to neutrophil cytoplasmic antigens. Kidney Int 1992;41:1059-1063.
50. Thompson JB, Hulse D, Galbraith I, McKay IC, Field M: Autoantibody associations with MHC class II antigens in scleroderma and autoimmune vasculitis. Autoimmunity 1994;19:265-269.
51. Hagen EC, Stegeman CA, D'Amaro J, Schreuder GMT, van Es LA, Cohen Tervaert JW, Kallenberg CGM, van der Woude FJ: Decreased frequency of HLA DR6/DR13 in patients with Wegener's granulomatosis Clin Exp Immunol 1995;101 (suppl I):55.
52. Zhang L, Jayne D, Zhao MH, Lockwood CM, Oliviera DBG: Distribution of MHC class II alleles in primary systemic vasculitis. Kidney Int 1995;47:294-298.
53. Kimura A, Sasazuki T: Eleventh International Histocompatability Workshop reference protocol for the HLA DNA-typing technique; in Tsuji K, Aizawa M, Sasazulki T (eds): Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford, Oxford University Press, 1992, pp 397-417.
54. Hunder GG, Arend DA, Bloch DA, Calabrese LH, Fauci AS, Fries JF, Leavitt RY, Lie JT, Lightfoot RW, Masi AT, Mcshane DJ, Michel BA, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ: The American College of Rheumatology 1990 criteria for the classification of vasculitis. Arthritis Rheum 1990;33:1065-1136.
55. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CGM, McCluskey RT, Sinico RA, Rees AJ, van Es LA, Waldherr R, Wiik A: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37: 187-192.
56. Elkon KB, Hughes GRV, Sutherland D, Rees AJ, Welsh KI, Batchelor JR: Increased frequency of HLA-B8 and DR2 in Wegener's granulomatosis and Churg-Strauss vasculitis (abstract). Ann Rheum Dis 1981;40:203.
57. Gaur A, Fathman CG: Immuno-therapeutic strategies directed at the trimolecular complex. Adv Immunol 1994;56:219-265.